Free Trial
→ AI Meltdown Imminent: Dump These Stocks Now! (From Paradigm Press) (Ad) Buy FENC Stock  Free FENC Stock Alerts

Fennec Pharmaceuticals (FENC) SEC Filings & 10K Form

Fennec Pharmaceuticals logo
$8.31 +0.06 (+0.73%)
Closing price 06/10/2025 04:00 PM Eastern
Extended Trading
$8.32 +0.00 (+0.06%)
As of 06/10/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Fennec Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
06/03/2025
3:31 PM		Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
4:01 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
4:02 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:42 PM		Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
4:21 PM		Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
5:23 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:03 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:03 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
6:29 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
3:12 PM		Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2025
6:12 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
6:13 PM		Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 4/A
04/03/2025
6:14 PM		Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4/A
04/03/2025
6:15 PM		Fennec Pharmaceuticals (Issuer)
Sayad Pierre Sargis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
6:16 PM		Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4/A
04/03/2025
5:10 PM		Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
5:11 PM		Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
5:12 PM		Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:17 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:18 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
3:46 PM		Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
4:32 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:29 PM		Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
5:51 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
5:53 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:13 PM		Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
12:00 PM		Fennec Pharmaceuticals (Subject)
Solas Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
11:06 AM		DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/05/2025
7:24 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:42 PM		Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
4:48 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:50 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:46 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:47 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
4:00 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:24 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:00 PM		Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
6:07 PM		Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
6:09 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:06 PM		Fennec Pharmaceuticals (Subject)
RALLIS CHRIS A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
4:02 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon’s backup plan for AI (Ad)

Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly becoming one of the most profitable stories of the year.

Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down.
11/13/2024
4:13 PM		Fennec Pharmaceuticals (Issuer)
Sayad Pierre Sargis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:14 PM		Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:15 PM		Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
6:38 PM		DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
3:46 PM		Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
4:30 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
4:30 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
6:00 AM		Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:14 PM		Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:11 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:13 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
4:02 PM		Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:33 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
5:48 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:30 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4/A
08/26/2024
4:51 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
5:59 PM		Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:00 PM		Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:00 PM		Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:01 PM		Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:02 PM		Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
5:56 PM		Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2024
4:10 PM		Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:30 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:21 PM		Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
4:55 PM		Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:42 PM		Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:43 PM		DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:FENC) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored